Name | BDA-366 |
---|---|
Synonyms |
9,10-Anthracenedione, 1-[[(2S)-3-(diethylamino)-2-hydroxypropyl]amino]-4-[[(2S)-oxiranylmethyl]amino]-
BDA-366 1-{[(2S)-3-(Diethylamino)-2-hydroxypropyl]amino}-4-{[(2S)-2-oxiranylmethyl]amino}-9,10-anthraquinone |
Description | BDA-366 is a potent Bcl2 antagonist (Ki = 3.3 nM), binding Bcl2-BH4 domain with high affinity and selectivity. BDA-366 induces conformational change in Bcl2 that abrogates its antiapoptotic function, converting it from a survival molecule to a cell death inducer. BDA-366 suppresses growth of lung cancer cells[1]. |
---|---|
Related Catalog | |
Target |
Bcl-2:3.3 nM (Ki) |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 669.4±55.0 °C at 760 mmHg |
Molecular Formula | C24H29N3O4 |
Molecular Weight | 423.50 |
Flash Point | 358.6±31.5 °C |
Exact Mass | 423.215820 |
LogP | 2.18 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.665 |
Storage condition | -20℃ |